Zydus Cadila receives FDA OK for generic Arranon

Zydus Cadila has received the Food and Drug Administration’s green light for Nelarabine injection.

The product is used to treat certain types of cancer.

[Read more: FDA gives tentative nod to Zydus Cadila's generic Truvada]

The medication is a generic of Arranon injection.

Zydus has been granted a competitive generic therapy designation for the product.

[Read more: Zydus Cadila gets FDA blessing for generic Otezla]

Therefore, it is eligible for 180 days of exclusivity.